Healthcare Industry News:  Animas  

Biopharmaceuticals Drug Delivery Mergers & Acquisitions

 News Release - February 17, 2006

Johnson & Johnson Completes Acquisition of Animas Corporation

NEW BRUNSWICK, N.J., Feb. 17 (HSMN NewsFeed) -- Johnson & Johnson (NYSE: JNJ ) today announced the completion of its previously announced acquisition of Animas Corporation, an insulin delivery company.

Johnson & Johnson is the world's most comprehensive and broadly based manufacturer of health care products, as well as a provider of related services, for the consumer, pharmaceutical, and medical devices and diagnostics markets. The more than 200 Johnson & Johnson operating companies employ approximately 115,600 men and women in 57 countries and sell products throughout the world.

Source: Johnson & Johnson

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.